Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients
- PMID: 6147290
- DOI: 10.1007/BF00253494
Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients
Abstract
The basal energy expenditure of 10 Type 1 (insulin-dependent) C-peptide-negative diabetic patients (2042 +/- 62 kcal/24 h) was found to be significantly higher than the 1774 +/- 52 kcal/24 h predicted from their age, sex and body surface area (p less than 0.01). Intravenous insulin treatment significantly reduced energy expenditure to 1728 +/- 19 kcal/24h (p less than 0.01), which matched predicted values. The observed increase in metabolic rate in uncontrolled diabetic patients is associated with increased protein turnover, increased plasma glucagon, but no significant increase in cortisol, growth hormone or triiodothyronine concentrations in plasma. It may be accounted for by the energy cost of protein synthesis, or gluconeogenesis, or possibly increased sympathetic activity. This increased energy expenditure will contribute to the weight loss seen in Type 1 diabetic patients.
Similar articles
-
Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate.Diabetes. 1998 Nov;47(11):1748-56. doi: 10.2337/diabetes.47.11.1748. Diabetes. 1998. PMID: 9792544
-
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13. doi: 10.1210/jc.2002-021873. J Clin Endocrinol Metab. 2003. PMID: 12788877
-
Twenty-four-hour energy expenditure in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia. 1992 Aug;35(8):753-9. doi: 10.1007/BF00429096. Diabetologia. 1992. PMID: 1511802
-
Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.J Clin Endocrinol Metab. 1990 Apr;70(4):1023-9. doi: 10.1210/jcem-70-4-1023. J Clin Endocrinol Metab. 1990. PMID: 2180971
-
Protein and energy metabolism in type 1 diabetes.Clin Nutr. 2010 Feb;29(1):13-7. doi: 10.1016/j.clnu.2009.09.001. Epub 2009 Sep 27. Clin Nutr. 2010. PMID: 19788950 Free PMC article. Review.
Cited by
-
Gene expression signature predicts rate of type 1 diabetes progression.EBioMedicine. 2023 Jun;92:104625. doi: 10.1016/j.ebiom.2023.104625. Epub 2023 May 22. EBioMedicine. 2023. PMID: 37224769 Free PMC article.
-
Morchella esculenta mushroom polysaccharide attenuates diabetes and modulates intestinal permeability and gut microbiota in a type 2 diabetic mice model.Front Nutr. 2022 Oct 6;9:984695. doi: 10.3389/fnut.2022.984695. eCollection 2022. Front Nutr. 2022. PMID: 36276816 Free PMC article.
-
Design of the Advancing Care for Type 1 Diabetes and Obesity Network energy metabolism and sequential multiple assignment randomized trial nutrition pilot studies: An integrated approach to develop weight management solutions for individuals with type 1 diabetes.Contemp Clin Trials. 2022 Jun;117:106765. doi: 10.1016/j.cct.2022.106765. Epub 2022 Apr 20. Contemp Clin Trials. 2022. PMID: 35460915 Free PMC article. Clinical Trial.
-
Ketones Elicit Distinct Alterations in Adipose Mitochondrial Bioenergetics.Int J Mol Sci. 2020 Aug 29;21(17):6255. doi: 10.3390/ijms21176255. Int J Mol Sci. 2020. PMID: 32872407 Free PMC article.
-
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials.Diabetes Obes Metab. 2020 Mar;22(3):303-314. doi: 10.1111/dom.13896. Epub 2019 Nov 14. Diabetes Obes Metab. 2020. PMID: 31608552 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical